Correlation Between Uniqure NV and Rocket Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Uniqure NV and Rocket Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Uniqure NV and Rocket Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Uniqure NV and Rocket Pharmaceuticals, you can compare the effects of market volatilities on Uniqure NV and Rocket Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Uniqure NV with a short position of Rocket Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Uniqure NV and Rocket Pharmaceuticals.

Diversification Opportunities for Uniqure NV and Rocket Pharmaceuticals

0.75

Correlation Coefficient

Uniqure NV  Rocket Pharmaceuticals

Poor diversification

The 3 months correlation between Uniqure and Rocket is 0.75. Overlapping area represents the amount of risk that can be diversified away by holding Uniqure NV and Rocket Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rocket Pharmaceuticals and Uniqure NV is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Uniqure NV are associated (or correlated) with Rocket Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rocket Pharmaceuticals has no effect on the direction of Uniqure NV i.e., Uniqure NV and Rocket Pharmaceuticals go up and down completely randomly.

Pair Corralation between Uniqure NV and Rocket Pharmaceuticals

Given the investment horizon of 90 days Uniqure NV is expected to generate 1.5 times more return on investment than Rocket Pharmaceuticals. However, Uniqure NV is 1.5 times more volatile than Rocket Pharmaceuticals. It trades about -0.06 of its potential returns per unit of risk. Rocket Pharmaceuticals is currently generating about -0.18 per unit of risk. If you would invest  1,722  in Uniqure NV on December 29, 2024 and sell it today you would lose (409.00) from holding Uniqure NV or give up 23.75% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Uniqure NV  vs.  Rocket Pharmaceuticals

Uniqure NV

Risk-Adjusted Performance

Very Weak

Over the last 90 days Uniqure NV has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in April 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Rocket Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Rocket Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's forward-looking signals remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Uniqure NV and Rocket Pharmaceuticals

The main advantage of trading using opposite Uniqure NV and Rocket Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Uniqure NV position performs unexpectedly, Rocket Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rocket Pharmaceuticals will offset losses from the drop in Rocket Pharmaceuticals' long position.

The idea behind Uniqure NV and Rocket Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.